ロード中...

In vivo Environment Swiftly Restricts Human Pancreatic Progenitors Toward Mono-Hormonal Identity via a HNF1A/HNF4A Mechanism

Generating insulin-producing β-cells from human induced pluripotent stem cells is a promising cell replacement therapy for improving or curing insulin-dependent diabetes. The transplantation of end-stages differentiating cells into living hosts was demonstrated to improve β-cell maturation. Neverthe...

詳細記述

保存先:
書誌詳細
出版年:Front Cell Dev Biol
主要な著者: Legøy, Thomas Aga, Mathisen, Andreas F., Salim, Zaidon, Vethe, Heidrun, Bjørlykke, Yngvild, Abadpour, Shadab, Paulo, Joao A., Scholz, Hanne, Ræder, Helge, Ghila, Luiza, Chera, Simona
フォーマット: Artigo
言語:Inglês
出版事項: Frontiers Media S.A. 2020
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7052484/
https://ncbi.nlm.nih.gov/pubmed/32161757
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fcell.2020.00109
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!